Deem, Angela K.
The University of Texas MD Anderson Cancer Center
4 papers on CoChatORCID 0000-0003-2101-2679
Most cited papers
- Verified
Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function
Viale, A., Pettazzoni, P., Lyssiotis, C. A., Ying, H., Sánchez, N., Marchesini, M., Carugo, A., Green, T., Seth, S., Giuliani, V., et al. (2014) · Nature
Pancreatic and Hepatic Oncology ResearchCancer, Hypoxia, and Metabolism
Cited by 1,259
- Verified
An inhibitor of oxidative phosphorylation exploits cancer vulnerability
Molina, J. R., Sun, Y., Protopopova, M., Gera, S., Bandi, M., Bristow, C., McAfoos, T., Morlacchi, P., Ackroyd, J., Agip, A.-N. A., et al. (2018) · Nature Medicine
Cancer, Hypoxia, and MetabolismMitochondrial Function and Pathology
Cited by 928
- Verified
Syndecan 1 is a critical mediator of macropinocytosis in pancreatic cancer
Yao, W., Rose, J. L., Wang, W., Seth, S., Jiang, H., Taguchi, A., Liu, J., Yan, L., Kapoor, A., Hou, P., et al. (2019) · Nature
Pancreatic and Hepatic Oncology ResearchProteoglycans and glycosaminoglycans research
Cited by 214
- Verified
Therapeutic targeting of syndecan-1 axis overcomes acquired resistance to KRAS-targeted therapy in gastrointestinal cancers
Theardy, M. S., Takeda, M., Sorokin, A., Chen, S., Yang, Z., Wang, X., Kanikarla, P., Coker, O., Nguyen, P., Wei, Y., et al. (2025) · Cell Reports Medicine
Protein Kinase Regulation and GTPase SignalingHippo pathway signaling and YAP/TAZ
Cited by 6
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free